Cip01 0028 01
Ciprofloxacin Injection, Solution
Product Images NDC 25021-114
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 25021-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Cip01 0028 02
This container contains Ciprofloxacin Injection USP with 200mg in 100mL 5% Dextrose, which must be infused over a period of 60 minutes as prescribed by a doctor. Each 100mL includes Ciprofloxacin 200mg, Dextrose Monohydrate 5g, Lactic Acid added as solubilizer, Water for Injection USP, and Hydrochloric Acid for pH adjustment to pH 3.5 to 4.6. The drug additives should not be made to this solution. It is a sterile, nonpyrogenic, and preservative-free single-dose flexible plastic container that includes a package insert. This container and container closure do not contain natural rubber latex. CAUTIONS: must not be used in series connections. If the solution is not clear, do not use. The accompanying Medication Guide must be dispensed to each patient. This product is manufactured by Sagent Pharmaceuticals in Switzerland, and it was batched and expires on an unknown date, labeled "Exp.Date."*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
